Retracted: Osimertinib Improves Overall Survival in Patients with Leptomeningeal Metastases Associated with EGFR-Mutated Non-Small-Cell Lung Cancer Regardless of Cerebrospinal Fluid T790M Mutational Status

Detalles Bibliográficos
Autor principal: and Alternative Medicine, Evidence-Based Complementary
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2023
Materias:
Retraction
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10356200/
https://www.ncbi.nlm.nih.gov/pubmed/37476338
http://dx.doi.org/10.1155/2023/9789654

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10356200/
https://www.ncbi.nlm.nih.gov/pubmed/37476338
http://dx.doi.org/10.1155/2023/9789654

Ejemplares similares